Tag results:
stem cell markers
Cancer Stem Cell News
Ethanol-Based Garlic Extract Prevents Malignant Evolution of Non-Invasive Breast Tumor Cells Induced by Moderate Hypoxia
[Biomedicine & Pharmacotherapy] Homemade ethanol-based garlic extract was administered to MCF7 and MCF10DCIS breast tumor cell lines grown under moderate hypoxia. Cell cycle, epithelial-to-mesenchymal transition and cancer stem cell markers were evaluated.
Cancer Stem Cell News
Up-Regulation of miR-663a Inhibits the Cancer Stem Cell-Like Properties of Glioma via Repressing the KDM2A-Mediated TGF-β/SMAD Signaling Pathway
[Cell Cycle] Investigators explored the role and underlying mechanism of miR-663a in the proliferation, migration, invasion, and cancer stem cell-like properties of glioma cells.
Prostate Cell News
Reduced DAPK1 Expression Promotes Stem Cell-Like Characteristics of Prostate Cancer Cells by Activating ZEB1 via Hippo/YAP Signaling Pathway
[Stem Cells and Development] Compared with tumor-adjacent normal tissues, death-associated protein kinase 1 (DAPK1) expression was reduced in prostate cancer cell lines with respect to that in normal prostate cells.
Cancer Stem Cell News
Preferential Interaction of Platelets with Prostate Cancer Cells with Stem Cell Markers
[Thrombosis Research] Scientists characterized the mechanisms behind prostate CSC-platelet interaction. Fluorescence Activated Cell Sorting was utilized to separate DU145 and PC3 prostate cancer cells into CD133+/CD44+, CD133+/CD44-, CD44+/CD133-, and CD133-/CD44- subpopulations and to measure their CXCR4 surface expression.
Cancer Stem Cell News
Expression of Cancer Stem Cell Markers in Tall Cell Variant Papillary Thyroid Cancer Identifies a Molecular Profile Predictive of Recurrence in Classic Papillary Thyroid...
[Surgery] Expression of CSC markers was examined in 572 thyroid tumors from The Cancer Genome Atlas Thyroid Cancer database and tall cell variant and papillary thyroid carcinoma tumors by immunohistochemistry.
Hematopoiesis News
Fenofibrate Increases Circulating Hematopoietic Stem Cells in People with Diabetic Retinopathy: A Randomized, Placebo-Controlled Trial
[Diabetologia] The authors investigated whether fenofibrate increased circulating hematopoietic stem/progenitor cells (HSPCs). When compared with placebo, fenofibrate significantly increased levels of HSPCs expressing CD34 and/or CD133.